5-Sep-2024 5:30 AM CST - Business Wire KalVista Pharmaceuticals Reports First Fiscal Quarter Results and Provides Operational Update KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today provided an operational update and released financial results for the first fiscal quarter ended July 31, 2024. We are excited about the steady progress weve made over the last few months including the most recent acceptance of our NDA by FDA and the EMAs validation of our MAA, said Ben Palleiko, CEO of KalVista. We look forward to building on these recent milestones as we move towa
5-Sep-2024 5:30 AM CST - Business Wire KalVista Pharmaceuticals Reports First Fiscal Quarter Results and Provides Operational Update KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today provided an operational update and released financial results for the first fiscal quarter ended July 31, 2024. We are excited about the steady progress weve made over the last few months including the most recent acceptance of our NDA by FDA and the EMAs validation of our MAA, said Ben Palleiko, CEO of KalVista. We look forward to building on these recent milestones as we move towa
